当前位置: 首页 >> 检索结果
共有 5290 条符合本次的查询结果, 用时 5.6691455 秒

4921. Gillian Hanson: UK innovator in intensive care medicine.

作者: Georgina Ferry.
来源: Lancet. 2022年399卷10332期1295页

4922. Angela Migowa: advocating for children with rheumatic diseases.

作者: Aarathi Prasad.
来源: Lancet. 2022年399卷10332期1294页

4923. Mixed response to COVID-19 intellectual property waiver.

作者: John Zarocostas.
来源: Lancet. 2022年399卷10332期1292-1293页

4924. Afghanistan's health crisis deepens under the Taliban.

作者: Sophie Cousins.
来源: Lancet. 2022年399卷10332期1290-1291页

4925. Offline: Resuscitating the white giants.

作者: Richard Horton.
来源: Lancet. 2022年399卷10332期1289页

4926. DNA vaccines join the fight against COVID-19.

作者: Anna K Blakney.;Linda-Gail Bekker.
来源: Lancet. 2022年399卷10332期1281-1282页

4927. Planetary health for the ages.

作者: The Lancet.
来源: Lancet. 2022年399卷10332期1279页

4928. Synthetic patient data in health care: a widening legal loophole.

作者: Anmol Arora.;Ananya Arora.
来源: Lancet. 2022年399卷10335期1601-1602页

4929. Medicinal licensing of e-cigarettes.

作者: Nicholas S Hopkinson.
来源: Lancet. 2022年399卷10335期1602-1603页

4930. An open letter to the Executive Board of WHO from the surgical and anaesthesia community.

作者: Anam N Ehsan.;Kee B Park.;Manon Pigeolet.
来源: Lancet. 2022年399卷10333期1380-1381页

4931. A plea for reproductive health support amid crisis in Lebanon.

作者: Duaa Fahs.;Dalal Kojok.;Jude Abiad.;Ghina Ghazeeri.
来源: Lancet. 2022年399卷10336期1692页

4932. Host-targeting oral antiviral drugs to prevent pandemics.

作者: Raymond A Dwek.;John I Bell.;Marc Feldmann.;Nicole Zitzmann.
来源: Lancet. 2022年399卷10333期1381-1382页

4933. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.

作者: Maaike C Swets.;Clark D Russell.;Ewen M Harrison.;Annemarie B Docherty.;Nazir Lone.;Michelle Girvan.;Hayley E Hardwick.; .;Leonardus G Visser.;Peter J M Openshaw.;Geert H Groeneveld.;Malcolm G Semple.;J Kenneth Baillie.
来源: Lancet. 2022年399卷10334期1463-1464页

4934. Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.

作者: Lola Kola.;Manasi Kumar.;Brandon A Kohrt.;Tobi Fatodu.;Bisola A Olayemi.;Adeyinka O Adefolarin.
来源: Lancet. 2022年399卷10338期1851-1852页

4935. Poaching doctors from abroad is unethical.

作者: J Meirion Thomas.
来源: Lancet. 2022年399卷10334期1466-1467页

4936. A call for an immediate ceasefire and peaceful end to the Russian aggression against Ukraine.

作者: .
来源: Lancet. 2022年399卷10332期1284-1287页

4937. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.

作者: .
来源: Lancet. 2022年399卷10331期1266-1278页
Most countries have made little progress in achieving the Sustainable Development Goal (SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable diseases (NCDs) by a third from 2015 to 2030. In this Health Policy paper, we synthesise the evidence related to interventions that can reduce premature mortality from the major NCDs over the next decade and that are feasible to implement in countries at all levels of income. Our recommendations are intended as generic guidance to help 123 low-income and middle-income countries meet SDG target 3.4; country-level applications require additional analyses and consideration of the local implementation and utilisation context. Protecting current investments and scaling up these interventions is especially crucial in the context of COVID-19-related health system disruptions. We show how cost-effectiveness data and other information can be used to define locally tailored packages of interventions to accelerate rates of decline in NCD mortality. Under realistic implementation constraints, most countries could achieve (or almost achieve) the NCD target using a combination of these interventions; the greatest gains would be for cardiovascular disease mortality. Implementing the most efficient package of interventions in each world region would require, on average, an additional US$18 billion annually over 2023-30; this investment could avert 39 million deaths and generate an average net economic benefit of $2·7 trillion, or $390 per capita. Although specific clinical intervention pathways would vary across countries and regions, policies to reduce behavioural risks, such as tobacco smoking, harmful use of alcohol, and excess sodium intake, would be relevant in nearly every country, accounting for nearly two-thirds of the health gains of any locally tailored NCD package. By 2030, ministries of health would need to contribute about 20% of their budgets to high-priority NCD interventions. Our report concludes with a discussion of financing and health system implementation considerations and reflections on the NCD agenda beyond the SDG target 3.4 and beyond the SDG period.

4938. Extraskeletal Ewing sarcoma of the duodenum presenting as duodenojejunal intussusception.

作者: Razeen Hassan.;Leow Voon Meng.;Kee Thian Ngee.;Lim I-Vern.;Padmaan Sankaran.;Lim Choon Hean.;Lee Euxian.;Haidi Mohamad.;Noraini Mohd Dusa.;Manisekar Subramaniam.
来源: Lancet. 2022年399卷10331期1265页

4939. Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.

作者: Jacklin F Mosha.;Manisha A Kulkarni.;Eliud Lukole.;Nancy S Matowo.;Catherine Pitt.;Louisa A Messenger.;Elizabeth Mallya.;Mohamed Jumanne.;Tatu Aziz.;Robert Kaaya.;Boniface A Shirima.;Gladness Isaya.;Monica Taljaard.;Jacklin Martin.;Ramadhan Hashim.;Charles Thickstun.;Alphaxard Manjurano.;Immo Kleinschmidt.;Franklin W Mosha.;Mark Rowland.;Natacha Protopopoff.
来源: Lancet. 2022年399卷10331期1227-1241页
Long-lasting insecticidal nets (LLINs) have successfully reduced malaria in sub-Saharan Africa, but their effectiveness is now partly compromised by widespread resistance to insecticides among vectors. We evaluated new classes of LLINs with two active ingredients with differing modes of action against resistant malaria vectors.

4940. Is open access a misnomer?

作者: Lauren Floyd.;Madelena Stauss.;Alexander Woywodt.
来源: Lancet. 2022年399卷10331期1226页
共有 5290 条符合本次的查询结果, 用时 5.6691455 秒